aTRPA1 antibody (Oblique Therapeutics)

N/A

Report date: 2025/03/14 16:29:43

Base Information

Drug NameaTRPA1 antibody (Oblique Therapeutics)
Drug Alias Nameanti-TRPA1 antibodies (Oblique Therapeutics)anti-transient receptor ankyrin-1 antibodies (Oblique Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTransient receptor potential cation channel subfamily A member 1 inhibitors
TargetsTransient receptor potential cation channel subfamily A member 1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOblique Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesOblique Therapeutics AB
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A